Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?

Rishi Chandiramani, Davide Cao, Roxana Mehran

Abstract

Non-ST-segment elevation acute coronary syndromes (NSTE-ACS) are responsible for almost 1 million admissions in the U.S. annually (1), and represent a spectrum of clinical conditions ranging from unstable angina (UA) to non-ST-segment elevation myocardial infarction (NSTEMI). The most important cause is intraluminal thrombosis due to atherosclerotic plaque rupture, which impairs distal blood flow and may lead to myocardial ischemia or infarction.

Article Options

Download Citation